Company Filing History:
2 out of 199 
1 out of 165 
Years Active: 2016-2019
Title: Brian Mark: Innovator in Biomedicine
Introduction
Brian Mark is a notable inventor based in Winnipeg, Canada. He has made significant contributions to the field of biomedicine, particularly through his innovative work on protein variants and their applications in treating genetic disorders.
Latest Patents
Brian Mark holds 2 patents that showcase his expertise in biochemistry. His latest patents include variants of β-hexosaminidase protein, which are useful for hydrolyzing GM2 ganglioside. These embodiments include a variant β-hexosaminidase subunit that forms a homodimer under physiological conditions and associates with Gactivator protein to hydrolyze Gganglioside. Additionally, he has developed live attenuated replication-competent arteriviruses with decreased DUB/deISGylating activity, which have potential applications as a medicament and vaccine.
Career Highlights
Throughout his career, Brian has worked with esteemed institutions such as the University of Manitoba and The Hospital for Sick Children. His research has focused on developing innovative solutions for complex medical challenges.
Collaborations
Brian has collaborated with notable professionals in his field, including Don J Mahuran and Marjolein Kikkert. These partnerships have further enhanced his research and contributions to biomedicine.
Conclusion
Brian Mark's innovative work in the field of biomedicine, particularly through his patents and collaborations, highlights his commitment to advancing medical science. His contributions are paving the way for new treatments and therapies for genetic disorders.